Pubblicazioni

Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma

2023 - JOURNAL OF NEURO-ONCOLOGY

Minniti, Giuseppe; Paolini, Sergio; Antonelli, Manila; Gianno, Francesca; Tini, Paolo; Lanzetta, Gaetano; Arcella, Antonella; De Pietro, Raffaella; Giraffa, Martina; Capone, Luca; Romano, Andrea; Bozzao, Alessandro; Esposito, Vincenzo

Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours

2021 - JOURNAL OF NEURO-ONCOLOGY

Oliva, M. A.; Staffieri, S.; Castaldo, S.; Giangaspero, F.; Esposito, V.; Arcella, A.

Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas

2020 - JOURNAL OF NEURO-ONCOLOGY

Minniti, G.; Paolini, S.; Rea, M. L. J.; Isidori, A.; Scaringi, C.; Russo, I.; Osti, M. F.; Cavallo, L.; Esposito, V.

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

2016 - JOURNAL OF NEURO-ONCOLOGY

Losa, M.; Bogazzi, F.; Cannavo, S.; Ceccato, F.; Curto, L.; De Marinis, L.; Iacovazzo, D.; Lombardi, G.; Mantovani, G.; Mazza, E.; Minniti, G.; Nizzoli, M.; Reni, M.; Scaroni, C.